New recommendations from the American Society of Echocardiography strongly endorse ultrasound guidance for most vascular access procedures while acknowledging evidence gaps.
FDA-cleared clinical trials will assess the safety, immunogenicity, and viability of genetically modified pig kidney transplants in patients with end-stage renal disease.
“Tranexamic acid significantly reduced the risk of perioperative bleeding without increasing cardiovascular risk in patients undergoing general surgery procedures,” said Lily J. Park, MD, MSc, and colleagues.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.
Keros Therapeutics halts testing of experimental blood pressure treatment due to safety concerns during mid-stage trial, citing excess fluid build up around the heart in patients with pulmonary arterial hypertension.